Fig. 7From: Engineered extracellular vesicles: potentials in cancer combination therapyEngineered EVs for the combination of cancer vaccine with immune checkpoint blockade. EVs derived from mature dendritic cells are modified with immune checkpoint inhibitors. These engineered EVs can realize the combination of cancer vaccine and immune checkpoint blockade, effectively activating T cells to inhibit tumor growthBack to article page